| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |